The global cold, cough, and sore throat remedy market is poised for steady growth over the next decade, driven by advancements in pharmaceutical solutions and the development of diverse dosage forms tailored for all age groups. The market is estimated to reach a valuation of US$ 42,618.7 million in 2024, with projections indicating growth to …